BioPharmSignal logoBioPharmSignal

Biotech News

Veradigm and Meperia Launch Industry-First 8-Way Match EDI Platform to Strengthen Healthcare Supply Chain Integrity

Veradigm (MDRX)VeradigmCommercial

A next-generation, hospital-first EDI platform delivering transparency, accuracy, and data governance to healthcare supply chains CHICAGO & VERO BEACH, Fla. --(BUSINESS WIRE)--Jan. 15, 2026-- Veradigm ® (OTCMKTS: MDRX), a leading provider of healthcare data, technology, and enterprise resource

Related news

MDRXVeradigm2026-02-13 13:01 EST

Veradigm Brings Patient Voice to Healthcare Research with New Real-World Data Survey Solution

MDRXVeradigm2026-05-26 20:10 EST

Veradigm Files 2023 and 2024 Form 10-K

View all latest news

Veradigm

Veradigm is a healthcare information and analytics company focused on software, data, and workflow tools for providers and life-sciences customers. Its business is more about information infrastructure than therapeutic innovation.

Recent company news

MDRXVeradigm2026-08-17 12:01 EST

Veradigm to Participate in Two Upcoming Investor Conferences

MDRXVeradigm2026-05-26 20:10 EST

Veradigm Files 2023 and 2024 Form 10-K

MDRXVeradigm2026-05-26 12:01 EST

Veradigm to Release Business Update May 26th and Host Investor Call May 27th

MDRXVeradigm2026-05-06 20:01 EST

Veradigm Launches Health Network Architecture to Level the Playing Field for Independent Practices

MDRXVeradigm2026-05-06 12:01 EST

Veradigm Survey: Independent Practices Rely on Technology to Stay Independent

Stock data

Close
4.97 USD
Market cap
—
Exchange
NASDAQ
Sector
Biopharma
Location
United States